DAVID MEEKER

Profile

First Name

: DAVID

Middle Name

:

Last Name

: MEEKER

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

INTRINERGY, LLC

STEVEN DAUPHIN, MATTHEW GOODWIN, ROBERT HARDIE, NORB HINTZ, MATTHEW HOLLAND, N/A INTRINERGY, INC., JOHN KEPPLER, CHRISTIAN LYNCH, THOMAS METH

DIRECTOR

TREVI THERAPEUTICS, INC.

METTE KIRSTINE AGGER, JAMES CASSELLA, DOMINICK COLANGELO, LISA DELFINI, CAYCE DENTON, WILLIAM FORBES, JENNIFER L. GOOD, MICHAEL HEFFERNAN, ED MATHERS, EDWARD MATHERS, ANNIE MITSAK, ERAN NADAV, THOMAS SCIASCIA, THOMAS R. SCIASCIA, CHRIS SEITER, JOSEPH SORRENTINO, OTELLO STAMPACCHIA, ANNE VANLENT

EXECUTIVE OFFICER

HULL STREET ENERGY PARTNERS III (PARALLEL), L.P.

CHARLES ARSENAULT, MICHAEL BOOTH, [NONE] HSE PARTNERS III GP, L.P., STEVEN MORRIS, MARK ORMAN, MATTHEW WILLIS, SARAH WRIGHT

EXECUTIVE OFFICER

HULL STREET ENERGY PARTNERS III, L.P.

CHARLES ARSENAULT, MICHAEL BOOTH, [NONE] HSE PARTNERS III GP, L.P., STEVEN MORRIS, MARK ORMAN, MATTHEW WILLIS, SARAH WRIGHT

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

OTHER INVESTMENT FUND

2024-05-31

D/A

OTHER INVESTMENT FUND

2024-02-29

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2022-04-11

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2021-10-18

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2021-10-05

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-07-14

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-07-14

D/A

OTHER ENERGY

DECLINE TO DISCLOSE

Debt

2008-11-04